Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.

Tachyplesin-1 (TP1; 1) is a cationic β-hairpin antimicrobial peptide with a membranolytic mechanism of action. While it possesses broad-spectrum, potent antimicrobial activity, 1 is highly hemolytic against mammalian erythrocytes, which precludes it from further development. In this study, we report a template-based approach to investigate the structure-function and structure-toxicity relationships of each amino acid of 1. We modulated charge and hydrophobicity by residue modification and truncation of the peptide. Antimicrobial activity was then assessed against six key bacterial pathogens and two fungi, with toxicity profiled against mammalian cells. The internal disulfide bridge Cys7-Cys12 of 1 was shown to play an important role in broad-spectrum antimicrobial activity against all pathogenic strains tested. Novel peptides based on the progenitor were then designed, including 5 (TP1[F4A]), 12 (TP1[I11A]), and 19 (TP1[C3A,C16A]). These had 26- to 64-fold improved activity/toxicity indices and show promise for further development. Structural studies of 5 (TP1[F4A]) and 12 (TP1[I11A]) identified a conserved β-hairpin secondary structure motif correlating with their very high stablility in mouse and human plasma. Membrane binding affinity determined by surface plasmon resonance confirmed their selectivity toward bacterial membranes, but the degree of membrane binding did not correlate with the degree of hemolysis, suggesting that other factors may drive toxicity.

[1]  F. Ke,et al.  Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms , 2016, Antimicrobial Agents and Chemotherapy.

[2]  M. Cooper,et al.  Antibiotics in the clinical pipeline at the end of 2015 , 2016, The Journal of Antibiotics.

[3]  Matthew A. Cooper,et al.  Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides , 2016, ACS infectious diseases.

[4]  D. Craik,et al.  Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae. , 2015, ACS chemical biology.

[5]  A. Ramamoorthy,et al.  Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy. , 2015, Chemistry and physics of lipids.

[6]  Yeji Park,et al.  Modified Cysteine-Deleted Tachyplesin (CDT) Analogs as Linear Antimicrobial Peptides: Influence of Chain Length, Positive Charge, and Hydrophobicity on Antimicrobial and Hemolytic Activity , 2014, International Journal of Peptide Research and Therapeutics.

[7]  T. Kikukawa,et al.  Interaction between tachyplesin I, an antimicrobial peptide derived from horseshoe crab, and lipopolysaccharide. , 2014, Biochimica et biophysica acta.

[8]  J. Torres,et al.  Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization. , 2012, Biochimica et biophysica acta.

[9]  Z. L. Huang,et al.  Tachyplesin I Induce Drug Resistance in Bacteria in vitro , 2012 .

[10]  Vassilios Ioannidis,et al.  ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..

[11]  K. Brogden,et al.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? , 2011, International journal of antimicrobial agents.

[12]  M. Meldal,et al.  Maintaining biological activity by using triazoles as disulfide bond mimetics. , 2011, Angewandte Chemie.

[13]  D. Craik,et al.  Decoding the Membrane Activity of the Cyclotide Kalata B1 , 2011, The Journal of Biological Chemistry.

[14]  Katsumi Matsuzaki,et al.  Control of cell selectivity of antimicrobial peptides. , 2009, Biochimica et biophysica acta.

[15]  M. Nishida,et al.  Action mechanism of tachyplesin I and effects of PEGylation. , 2007, Biochimica et biophysica acta.

[16]  Robert E W Hancock,et al.  Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index* , 2005, Journal of Biological Chemistry.

[17]  A. Laederach,et al.  Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives. , 2002, Biochemistry.

[18]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[19]  J. Tam,et al.  Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. , 2000, Biochemical and biophysical research communications.

[20]  K Nishikawa,et al.  Strong hydrophobic nature of cysteine residues in proteins , 1999, FEBS letters.

[21]  P. Somerharju,et al.  Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Hodges,et al.  1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects , 1995, Journal of biomolecular NMR.

[23]  H. Tamamura,et al.  Antimicrobial activity and conformation of tachyplesin I and its analogs. , 1993, Chemical & pharmaceutical bulletin.

[24]  T. Yoneya,et al.  Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). NMR determination of the beta-sheet structure. , 1990, The Journal of biological chemistry.

[25]  T. Yoneya,et al.  Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. , 1989, Journal of biochemistry.

[26]  T. Miyata,et al.  Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.

[27]  G. Salvioli,et al.  Membrane lipid composition of red blood cells in liver disease: regression of spur cell anaemia after infusion of polyunsaturated phosphatidylcholine , 1978, Gut.

[28]  P. Panteleev,et al.  Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity , 2017, Biotechnology and applied biochemistry.

[29]  Xiaohua Jiang,et al.  Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry. , 2015, Microbiological research.

[30]  D. Craik,et al.  Cyclotide isolation and characterization. , 2012, Methods in enzymology.

[31]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[32]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[33]  W. J. Powers,et al.  An improved resazurin-based cytotoxicity assay for hepatic cells , 2004, Cell Biology and Toxicology.

[34]  A. Rao,et al.  Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. , 1999, Archives of biochemistry and biophysics.

[35]  G. Cooper.  The Cell: A Molecular Approach , 1996 .

[36]  B D Sykes,et al.  1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects , 1995, Journal of biomolecular NMR.

[37]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[38]  Takanori Nakamura,et al.  Tachyplesin, a Class of Antimicrobial Peptide from the Hemocytes of the Horseshoe Crab (Tach ypleus tridentatus) , 1988 .